Lidoderm and Cabometyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lidoderm (lidocaine) and Cabometyx (cabozantinib s-malate). Common drug interactions include death among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Lidoderm and Cabometyx. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

On Jul, 21, 2026

24 people who take Lidoderm and Cabometyx together, and have interactions are studied.

Lidoderm and Cabometyx drug interactions.

What are the common drug interactions of Lidoderm and Cabometyx, by gender? *:

female:

Death
Asthenia (weakness)
Blood pressure decreased
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dizziness
Electrolyte depletion (act of decreasing electrolyte markedly)
Gastrointestinal motility disorder (abnormal intestinal contractions)
Haematemesis (vomiting of blood)
Hypervolaemia (abnormally increased volume of blood)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

male:

Nausea (feeling of having an urge to vomit)
Decreased appetite
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dyspnoea (difficult or laboured respiration)
Mucosal inflammation (infection of mucous membrane)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary mass

What are the common drug interactions of Lidoderm and Cabometyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Malignant neoplasm progression (cancer tumour came back)
Platelet count decreased

50-59:

Thrombosis (formation of a blood clot inside a blood vessel)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Nausea (feeling of having an urge to vomit)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary mass
Renal mass (mass in kidney)
Vomiting
Decreased appetite
Depression

60+:

Death
Asthenia (weakness)
Metastases to kidney (cancer spreads to kidney)
Metastases to liver (cancer spreads to liver)
Metastases to muscle (cancer spreads to muscle)
Nausea (feeling of having an urge to vomit)
Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
Oedema peripheral (superficial swelling)
Pallor
Pericardial effusion (fluid around the heart)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 21 people, 87.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lidoderm and Cabometyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously